标题
Shining a light in the black box of orphan drug pricing
作者
关键词
Pricing, Price setting, Orphan drugs
出版物
Orphanet Journal of Rare Diseases
Volume 9, Issue 1, Pages 62
出版商
Springer Nature
发表日期
2014-04-27
DOI
10.1186/1750-1172-9-62
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Reforming the Payment System for Medical Oncology
- (2013) Peter B. Bach JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sustainable rare diseases business and drug access: no time for misconceptions
- (2013) Pierrick Rollet et al. Orphanet Journal of Rare Diseases
- Reconciling uncertainty of costs and outcomes with the need for access to orphan medicinal products: a comparative study of managed entry agreements across seven European countries
- (2013) Thomas Morel et al. Orphanet Journal of Rare Diseases
- A Pilot Study of Multicriteria Decision Analysis for Valuing Orphan Medicines
- (2013) Jon Sussex et al. VALUE IN HEALTH
- Differential pricing of new pharmaceuticals in lower income European countries
- (2013) Zoltán Kaló et al. Expert Review of Pharmacoeconomics & Outcomes Research
- The weight of nations: an estimation of adult human biomass
- (2012) Sarah Catherine Walpole et al. BMC PUBLIC HEALTH
- Orphan drug development: an economically viable strategy for biopharma R&D
- (2012) Kiran N. Meekings et al. DRUG DISCOVERY TODAY
- SOCIETAL VIEWS ON NICE, CANCER DRUGS FUND AND VALUE-BASED PRICING CRITERIA FOR PRIORITISING MEDICINES: A CROSS-SECTIONAL SURVEY OF 4118 ADULTS IN GREAT BRITAIN
- (2012) Warren G. Linley et al. HEALTH ECONOMICS
- Market uptake of orphan drugs - a European analysis
- (2012) E. Picavet et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Paying for the Orphan Drug System: break or bend? Is it time for a new evaluation system for payers in Europe to take account of new rare disease treatments?
- (2012) Wills Hughes-Wilson et al. Orphanet Journal of Rare Diseases
- What Is Wrong with Orphan Drug Policies?
- (2012) André Côté et al. VALUE IN HEALTH
- What Is Wrong with Orphan Drug Policies? Suggestions for Ways Forward
- (2012) Panos Kanavos et al. VALUE IN HEALTH
- Access to orphan drugs in Europe: current and future issues
- (2012) Morgane Michel et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Pricing and reimbursement of orphan drugs: the need for more transparency
- (2011) Steven Simoens Orphanet Journal of Rare Diseases
- The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases
- (2011) Brigitta E Miyamoto et al. Orphanet Journal of Rare Diseases
- Estimating the budget impact of orphan medicines in Europe: 2010 - 2020
- (2011) Carina Schey et al. Orphanet Journal of Rare Diseases
- Drugs for Rare Diseases: Influence of Orphan Designation Status on Price
- (2011) Eline Picavet et al. Applied Health Economics and Health Policy
- Review of regulatory recommendations for orphan drug submissions in the netherlands and scotland: focus on the underlying pharmacoeconomic evaluations
- (2010) Stefan Vegter et al. CLINICAL THERAPEUTICS
- Budget impact analysis of orphan drugs in Belgium: estimates from 2008 to 2013
- (2010) Alain Denis et al. JOURNAL OF MEDICAL ECONOMICS
- Expensive drugs for rare disorders: to treat or not to treat? The case of enzyme replacement therapy for mucopolysaccharidosis VI
- (2009) M. Schlander et al. CURRENT MEDICAL RESEARCH AND OPINION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started